Product Name:

PKG1-pT515+pT517


Product Number:

ab-pk776

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: cGMP-dependent protein kinase 1, alpha isozyme

Target Alias: cGK 1 alpha; cGKI-alpha; cGKI-beta; cGMP-dependent protein kinase 1, alpha isozyme; DKFZp686K042; FLJ36117; KGP1A; Kinase PKG1; PGK; PKG; PKG1-alpha; Protein kinase, cGMP-dependent, type I

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK776

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: T515+T517

Protein UniProt: Q13976

Protein SigNET: Q13976

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human PKG1a (PRKG1A) sequence peptide Cat. No.: PE-04ARO99

Antibody Immunogen Sequence: FGKK(pT)W(pT)FCG(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues F511 to G521; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.

Production Method: Corresponds to amino acid residues F511 to G521; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.

Antibody Modification: Protein kinase phosphosite-specific antibody

Antibody Concentration: 0.3 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 77-83 kDa.

Scientific Background: PKG1 (PRKG1) is a protein-serine/threonine kinase of the AGC group and PKG family. It is activated by cGMP, which is generated in response to nitric oxide. Phosphorylation at T59 increases phosphotransferase activity and its affinity for cGMP Phosphorylation at T517 increases phosphotransferase activity. An R177Q mutation in AAT8 results in a constitutively active form of PKG1, which also has reduced cGMP binding.